Research
Pioneering Scientific Research
Research
Behavioral Research
Biostatistics
Cell & Gene Therapy
Cell Biology
Data Science
Diagnostics & Biomarkers
Disease Prevention
Epidemiology
Gene Regulation & Expression
Genetics & Genomics
Global Health
Health Economics
Hematopoietic Transplantation
Immunotherapy
Infectious Diseases
Microbiome
Survivorship
Vaccine Development
Virology
Diseases
Autoimmune Diseases
Cancers
New
Coronavirus (COVID-19)
Genetic Disorders
HIV/AIDS
Divisions
Basic Sciences Division
Clinical Research Division
Human Biology Division
Public Health Sciences Division
Vaccine and Infectious Disease Division
Patient Treatment & Support
FAQ
Make an Appointment
Meet Our Clinicians
Patient Stories
Clinical Trials & Studies
COVID-19 Clinical Research Center
Education & Training
Faculty & Lab Directory
Institutes, Networks & IRCs
Scientific Publications
Shared Resources
Investors & Industry
Collaborating for Cures
Business Development
Available Technologies
Collaborations & Startups
Commercialization
Events & Conferences
Team
News
Driving Innovation
Shared Facilities
GMP Manufacturing
Team Science
Data-Intensive Bioscience
Contact Us
About Us
Cures Start Here
About The Hutch
Accountability & Impact
Annual Report
Diversity, Equity & Inclusion
Facilities & Infrastructure
History
Honors & Awards
Institutional Partners & Collaborations
Leadership
Mission & Values
Contact Us
Campus Map
Scientific Staff Directory
Global Locations
Careers
Internships
Educational Outreach
Events and Seminars
For the Media
Ways to Give
Why Your Gift Matters
Give Now
Honor a Loved One
Give Through Your Will
Give Through Your Foundation
Create an Endowment
Make a Corporate Gift
Join a Gift Club
Attend a Virtual Event
Fundraise for Fred Hutch
Log In to Your Fundraiser
Fearless Science Needs Us
Support Our Science
Other Ways to Give
Give Monthly
Give at Work
Donate Your Vehicle
Donate Stock
Contact Philanthropy
Careers
News
Contact
Donate
Now
Research
Pioneering Scientific Research
Research
Research
Behavioral Research
Biostatistics
Cell & Gene Therapy
Cell Biology
Data Science
Diagnostics & Biomarkers
Disease Prevention
Epidemiology
Gene Regulation & Expression
Genetics & Genomics
Global Health
Health Economics
Hematopoietic Transplantation
Immunotherapy
Infectious Diseases
Microbiome
Survivorship
Vaccine Development
Virology
Diseases
Diseases
Autoimmune Diseases
Cancers
New
Coronavirus (COVID-19)
Genetic Disorders
HIV/AIDS
Divisions
Divisions
Basic Sciences Division
Clinical Research Division
Human Biology Division
Public Health Sciences Division
Vaccine and Infectious Disease Division
Patient Treatment & Support
Patient Treatment & Support
FAQ
Make an Appointment
Meet Our Clinicians
Patient Stories
Clinical Trials & Studies
COVID-19 Clinical Research Center
Education & Training
Faculty & Lab Directory
Institutes, Networks & IRCs
Scientific Publications
Shared Resources
Investors & Industry
Collaborating for Cures
Business Development
Business Development
Available Technologies
Collaborations & Startups
Commercialization
Events & Conferences
Team
News
Driving Innovation
Driving Innovation
Shared Facilities
GMP Manufacturing
Team Science
Data-Intensive Bioscience
Contact Us
About Us
Cures Start Here
About The Hutch
About The Hutch
Accountability & Impact
Annual Report
Diversity, Equity & Inclusion
Facilities & Infrastructure
History
Honors & Awards
Institutional Partners & Collaborations
Leadership
Mission & Values
Contact Us
Contact Us
Campus Map
Scientific Staff Directory
Global Locations
Careers
Internships
Educational Outreach
Events and Seminars
For the Media
Ways to Give
Why Your Gift Matters
Give Now
Honor a Loved One
Give Through Your Will
Give Through Your Foundation
Create an Endowment
Make a Corporate Gift
Join a Gift Club
Attend a Virtual Event
Fundraise for Fred Hutch
Fundraise for Fred Hutch
Log In to Your Fundraiser
Fearless Science Needs Us
Support Our Science
Other Ways to Give
Other Ways to Give
Give Monthly
Give at Work
Donate Your Vehicle
Donate Stock
Contact Philanthropy
Careers
News
Contact
Donate Now
Business Development News
Business Development
Search and Filter
Apply
Clear all
Results per Page:
20
5
10
20
50
100
Hutch research helps launch new genomic medicine company
Ensoma receives $70 million in financing to develop genome modification technologies via a single injection
Hutch News - February 11, 2021
Tags
human molecular genetics
business development and strategy
Hans-Peter Kiem
Kiem Lab
hematopoietic stem cell
hematopoietic stem cell transplant
cell and gene therapy
gene editing
Clinical Research
Share
What's next for T-cell therapies: Q&A with Dr. Stanley Riddell
After approval of latest cellular therapy for non-Hodgkin lymphoma, the immunologist looks ahead
Hutch News - February 05, 2021
Tags
hematopoietic transplantation
immunotherapy
Stanley R Riddell
Geoffrey Hill
David G Maloney
Damian Green
Bezos Family Immunotherapy Clinic
IIRC
CAR t-cell
Juno Therapeutics
u.s. food and drug administration
non-hodgkin lymphoma
Markers of B-Cell Stimulation as Potential Predictors of Non-Hodgkin Lymphoma
Share
New awards to spur innovation, commercialization in life sciences research
Funding from Washington Research Foundation continues longstanding collaboration with Fred Hutch
Hutch News - February 01, 2021
Tags
business development
philanthropy
Taran Gujral
Human Biology
Tumor specific translational research
lung disease
artificial intelligence
commercialization
Good News
Share
How Fred Hutch is using science to get back to doing science
Physical distancing, masks, testing and lots of research drive 'back-to-campus' strategy
Hutch News - May 19, 2020
Tags
COVID-19
Steven Pergam
Nicole Robinson
Julie McElrath
Trevor Bedford
McElrath Lab
Vaccine and Infectious Disease
coronavirus
Seattle Cancer Care Alliance
Share
Inside scorpion venom: A future Rx for arthritis?
Tiny scorpion-derived proteins deliver arthritis drugs to joints in rat study
Hutch News - March 04, 2020
Tags
Jim Olson
Clinical Research
Rheumatoid Arthritis
protein engineering
Project Violet
optides
tumor paint
Blaze Biosciences
Share
Fred Hutch research a GeekWire Award finalist for Health Innovation of the Year
Other finalists include Fred Hutch spinoffs Adaptive Biotechnologies and Blaze Bioscience
Hutch News - February 19, 2020
Tags
Matthias Stephan
Clinical Research
CAR t-cell
bioengineering
immunology
Good News
Adaptive Biotechnologies
Blaze Biosciences
Transplant and Immunotherapy
Stephan Lab
Ovarian Cancer
Share
High-altitude altruism: Seeking cures at 17,600 feet
Fred Hutch scientist, senior leader will hike the Himalayas to raise money for cancer research
Hutch News - February 14, 2020
Tags
Jennifer Adair
Adair Lab
Nicole Robinson
Climb to Fight Cancer
mountain climbing
Share
Failed Alzheimer’s drug boosts CAR T-cell therapy
Engineered immune cells get a helping hand in new clinical trial for multiple myeloma patients
Hutch News - September 26, 2019
Tags
Multiple Myeloma
Transplant and Immunotherapy
Damian Green
Stanley R Riddell
chimeric antigen receptor
genetically engineered t cells
Juno Therapeutics
clinical trials
Clinical Research
american society of hematology
scientific conferences
ASH
ASH 2019
Share
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
Hutch News - August 02, 2019
Tags
Public Health Sciences
Clinical Research
Vaccine and Infectious Disease
Human Biology
Cyrus Ghajar
Slobodan Beronja
Geoff Hill Lab
Andrew McGuire
Sujatha Srinivasan
David Fredricks
Chapuis Lab
Anton Sholukh
Lucas Sullivan
business development and strategy
Roland K Strong
metastatic breast cancer
Ovarian Cancer
cytomegalovirus
bone marrow transplantation
epstein-barr virus
bacterial vaginosis
myeloproliferative disorders
TCR
Acute Lymphoblastic Leukemia
Good News
commercialization
Share
Study aims to cure blood cancers with transplants that could block HIV, too
10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene
Hutch News - November 16, 2018
Tags
Colleen Delaney
Nohla Therapeutics
cord blood transplant
Filippo Milano
HIV Cure
HIV AIDS
Leukemia
Cord Blood Program
Timothy Ray Brown
Good News
Clinical Research
Share
Seattle Times' Pacific NW Magazine profiles Fred Hutch
Seattle Times’ Sunday feature looks at the melding of expertise, drive and technology making new cures possible
Hutch News - May 17, 2018
Tags
Pacific NW Magazine
Fred Hutch
closing in on a cure
D. Gary Gilliland
Cures2025
curative therapies
next generation immunotherapies
immunotherapy
bone marrow transplantation
blood cancer
Leukemia
Lymphoma
business development
business development and strategy
partnerships
Share
A focus on partnerships at Hutch/Merck summit
Research on the immune system aims to stop infectious diseases and cancer
Hutch News - May 11, 2018
Tags
infection-related cancers
D. Gary Gilliland
Nicole Robinson
business development and strategy
Business Development
Denise Galloway
Human Biology
Julie McElrath
Vaccine and Infectious Disease Division (VIDD)
Vaccine development - Viral cancers
Share
Data drives life sciences boom in Seattle
Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference
Hutch News - March 30, 2018
Tags
big data
D. Gary Gilliland
Matthew Trunnell
Denise Galloway
Leland Hartwell
Christine Gregoire
Cancers
biotech
Adaptive Biotechnologies
Nohla Therapeutics
life sciences discovery fund
immune system
immunotherapy
Immunology
cancer research
malaria
Director's Office
Cancer etiology - prevention - outcomes
Human Biology
Christopher J Kemp
Vijayakrishna Gadi
Eddie Mendez
Clinical Research
Colleen Delaney
Translational Data Science Integrated Research Center
hutch data commonwealth
Share
Scientists-turned-entrepreneurs share lessons learned launching startups
From venture capital to office space to acquisitions, academics starting companies face a steep learning curve — but there’s help to be found
Hutch News - March 26, 2018
Tags
Basic Sciences
Clinical Research
Vaccine and Infectious Disease
Public Health Sciences
Business Development
business development and strategy
Mark B Roth
Colleen Delaney
Raphael Gottardo
startups
licensing technology
cord blood transplant
cord blood
suspended animation
computational biology
Nohla Therapeutics
Share
Seattle mayor eager to realize the future of health care right here
Jenny Durkan addresses local life sciences representatives at Hutch roundtable
Hutch News - March 05, 2018
Tags
Bruce E Clurman
Director's Office
Nicole Robinson
Business Development
Good News
Share
Drs. Beverly Torok-Storb, Colleen Delaney receive Seattle AWIS Awards
Honored for excellence in science education, advancement and STEM leadership
Hutch News - February 28, 2018
Tags
Beverly Torok-Storb
Colleen Delaney
Clinical Research
Cord Blood Program
Transplantation Biology
science education
Nancy Davidson
Human Biology
Seattle Cancer Care Alliance (SCCA)
Nohla Therapeutics
endowed chair
Good News
Share
Luke Timmerman to scale Mount Everest for Fred Hutch research
Seattle writer will head to the top of the world in Climb to Fight Cancer
Hutch News - February 27, 2018
Tags
Luke Timmerman
Climb to Fight Cancer
mountain climbing
fundraiser
cancer research
Nicole Robinson
Seattle Cancer Summit
Share
Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy
Immune-based treatments move from the fringes to the spotlight
Hutch News - June 16, 2017
Tags
immunotherapy
Transplant and Immunotherapy
Clinical Research
Sylvia Lee
Renato Martins
Philip D Greenberg
Michael Jensen
Juno Therapeutics
Adaptive Biotechnologies
chimeric antigen receptor
adoptive t cell therapy
CAR t-cell
tumor infiltrating lymphocyte
checkpoint inhibitors
Lung Cancer
Melanoma
Leukemia
pediatric
Share
Good News: GeekWire Award Finalists include Bezos Family Immunotherapy Clinic and Nohla Therapeutics, among others
Celebrating faculty and staff achievements
Hutch News - April 13, 2017
Tags
Bezos Family Immunotherapy Clinic
Bezos
Colleen Delaney
Nohla Therapeutics
Transplant and Immunotherapy
Cord Blood Program
Women in Science
Taran Gujral
Basic Sciences Division
Human Biology
Public Health Sciences
Arvind Subramaniam
Harlan Robins
Share
Good News: $8.8 million NIH grant; Evergreen Fund to accelerate commercialization of research; Hutch United co-chair receives fellowship
Celebrating faculty and staff achievements
Hutch News - December 29, 2016
Tags
ColoCare
colon cancer
Christopher Li
Nicole Robinson
Business Development
commercialization
Hutch United
diversity
Hutch Award
Public Health Sciences
Transplant and Immunotherapy
Molecular basis of cancer
Share
Fred Hutchinson Cancer Research Center
Investors & Industry
Business Development
News
Last Modified, August 05, 2019